Dynamic range of GSK3α not GSK3β is essential for bidirectional synaptic plasticity at hippocampal CA3-CA1 synapses

AZD1080, a novel GSK3 inhibitor, rescues synaptic plasticity deficits in rodent brain and exhibits peripheral target engagement in humans

(2013) Biljana Georgievska et al.   JOURNAL OF NEUROCHEMISTRY

Rare Variants in Calcium Homeostasis Modulator 1 (CALHM1) Found in Early Onset Alzheimer’s Disease Patients Alter Calcium Homeostasis

(2013) Fanny Rubio-Moscardo et al.   PLoS One

A pivotal role of GSK-3 in synaptic plasticity

(2012) Clarrisa A. Bradley et al.   Frontiers in Molecular Neuroscience

Distinct Molecular Regulation of Glycogen Synthase Kinase-3α Isozyme Controlled by Its N-terminal Region

(2011) Inbar Azoulay-Alfaguter et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

GSK-3: Functional Insights from Cell Biology and Animal Models

(2011) Oksana Kaidanovich-Beilin et al.   Frontiers in Molecular Neuroscience

The role of GSK3 in Alzheimer disease

(2009) Félix Hernández et al.   BRAIN RESEARCH BULLETIN

Glycogen synthase kinase 3: more than a namesake

(2009) Geetha Vani Rayasam et al.   BRITISH JOURNAL OF PHARMACOLOGY

GSK-3: A key player in neurodegeneration and memory

(2009) Karl Peter Giese   IUBMB LIFE

The role of GSK-3 in synaptic plasticity

(2008) S Peineau et al.   BRITISH JOURNAL OF PHARMACOLOGY

GSK-3β Is Required for Memory Reconsolidation in Adult Brain

(2008) Tetsuya Kimura et al.   PLoS One